05/16/2024 5:10 PM | Applied Therapeutics (Subject) Hansard Adam (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024 6:13 AM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:17 AM | Applied Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024 11:15 PM | Applied Therapeutics (Filer)
| Form EFFECT | |
04/25/2024 3:33 PM | Applied Therapeutics (Filer)
| Form 424B3 | |
04/22/2024 3:37 PM | Applied Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024 3:38 PM | Applied Therapeutics (Filer)
| Form DEFA14A | |
|
04/22/2024 3:39 PM | Applied Therapeutics (Filer)
| Form ARS | |
04/15/2024 4:27 PM | Applied Therapeutics (Issuer) Hooks Corwin Dale (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/15/2024 4:30 PM | Applied Therapeutics (Issuer) Hooks Corwin Dale (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 4:00 PM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 3:41 PM | Applied Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024 3:31 PM | Applied Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/18/2024 4:57 PM | Applied Therapeutics (Issuer) Funtleyder Leslie D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 5:00 PM | Applied Therapeutics (Issuer) Hansard Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 5:02 PM | Applied Therapeutics (Issuer) Perfetti Riccardo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 5:12 PM | Applied Therapeutics (Issuer) Shendelman Shoshana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 4:49 PM | Applied Therapeutics (Issuer) Chinoporos Constantine (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/18/2024 4:51 PM | Applied Therapeutics (Issuer) Chinoporos Constantine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:42 PM | Applied Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/11/2024 7:17 AM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2024 2:17 PM | Applied Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
03/06/2024 6:19 AM | Applied Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/06/2024 6:12 AM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 4:42 PM | Applied Therapeutics (Subject) Shendelman Shoshana (Filed by)
| Form SC 13D/A | |
02/29/2024 3:18 PM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 1:26 PM | Applied Therapeutics (Subject) Propel Bio Management, LLC (Filed by)
| Form SC 13G/A | |
02/15/2024 6:07 AM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:20 PM | Applied Therapeutics (Subject) Applied Therapeutics (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 5:30 PM | Applied Therapeutics (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 3:22 PM | ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by) Applied Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 1:40 PM | Applied Therapeutics (Subject) ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 12:50 PM | Alyeska Investment Group, L.P. (Filed by) Applied Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 7:35 AM | Applied Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024 7:49 AM | Applied Therapeutics (Subject) FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
01/03/2024 8:15 AM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 3:23 PM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/22/2023 7:01 PM | Applied Therapeutics (Issuer) Hansard Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 7:01 PM | Applied Therapeutics (Issuer) Perfetti Riccardo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 7:01 PM | Applied Therapeutics (Issuer) Shendelman Shoshana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 11:29 AM | Applied Therapeutics (Subject) FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (Ad) Man who spotted Apple at $1.49 says: "Buy These 6 AI Stocks." And these will be the biggest winners |
12/06/2023 3:15 PM | Applied Therapeutics (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
12/05/2023 6:03 PM | Applied Therapeutics (Issuer) Kanter Stacy J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 6:42 PM | Applied Therapeutics (Issuer) Perfetti Riccardo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 6:42 PM | Applied Therapeutics (Issuer) Shendelman Shoshana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 6:42 PM | Applied Therapeutics (Issuer) Hansard Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 5:53 PM | Alexandria Equities No. 7, LLC (Reporting) ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting) Alexandria Venture Investments, LLC (Reporting) Applied Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 3:41 PM | Applied Therapeutics (Issuer) Funtleyder Leslie D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 4:10 PM | Applied Therapeutics (Subject) Shendelman Shoshana (Filed by)
| Form SC 13D/A | |
11/09/2023 6:47 AM | Applied Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023 6:36 AM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 3:37 PM | Alexandria Venture Investments, LLC (Reporting) Applied Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 3:44 PM | Alexandria Equities No. 7, LLC (Reporting) ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting) Alexandria Venture Investments, LLC (Reporting) Applied Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 3:33 PM | Alexandria Venture Investments, LLC (Reporting) Applied Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023 3:42 PM | Alexandria Venture Investments, LLC (Reporting) Applied Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2023 3:42 PM | Alexandria Venture Investments, LLC (Reporting) Applied Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2023 6:17 PM | Alexandria Equities No. 7, LLC (Reporting) ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting) Alexandria Venture Investments, LLC (Reporting) Applied Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2023 3:42 PM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2023 7:02 PM | Applied Therapeutics (Issuer) Hansard Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 7:02 PM | Applied Therapeutics (Issuer) Perfetti Riccardo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 7:03 PM | Applied Therapeutics (Issuer) Shendelman Shoshana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2023 7:08 PM | Applied Therapeutics (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 6:12 AM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 3:50 PM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 6:40 AM | Applied Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 6:07 AM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 3:40 PM | Applied Therapeutics (Issuer) Thorpe Catherine (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/16/2023 3:40 PM | Applied Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/08/2023 8:01 PM | Applied Therapeutics (Issuer) Funtleyder Leslie D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 8:02 PM | Applied Therapeutics (Issuer) Kanter Stacy J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 8:02 PM | Applied Therapeutics (Issuer) Lerner Teena (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 8:03 PM | Applied Therapeutics (Issuer) MARCUS JOEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 8:03 PM | Applied Therapeutics (Issuer) SKYLER JAY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2023 11:15 PM | Applied Therapeutics (Filer)
| Form EFFECT | |